02.02.15
French company Implanet has been granted intellectual property rights to its Jazz technology in Europe until 2031. This patent applies to the entire JAZZ system and definitively secures full protection of the implant’s technical characteristics.
“This announcement validates the excellent upstream work accomplished by our research and development team to put in place long-term barriers to entry, by significantly reducing any possible attempts to develop a rival product,” said CEO Ludovic Lastennet. “We can now capitalize on this patent to accelerate JAZZ’s transformation into a technological platform comprising a comprehensive range of implants covering 100 percent of our market. Our highly-promising portfolio of innovations will enable us to rapidly meet the demands of the entire spine surgeon community.”
Implanet makes orthopedic implants, specializing in vertebral and knee-surgery implants.
“This announcement validates the excellent upstream work accomplished by our research and development team to put in place long-term barriers to entry, by significantly reducing any possible attempts to develop a rival product,” said CEO Ludovic Lastennet. “We can now capitalize on this patent to accelerate JAZZ’s transformation into a technological platform comprising a comprehensive range of implants covering 100 percent of our market. Our highly-promising portfolio of innovations will enable us to rapidly meet the demands of the entire spine surgeon community.”
Implanet makes orthopedic implants, specializing in vertebral and knee-surgery implants.